Cell-Mediated Drug Delivery: From Carriers to Therapeutics
Pharmaceutics · 20.07.2026 · 18 (7) · 890
DOI: 10.3390/pharmaceutics18070890 ↗Kurz gefasst
Editorial in der Zeitschrift Pharmaceutics, online erschienen am 20.07.2026. Verfasst von Lisa Gherardini und 1 weiteren Autor:innen. Beteiligte Einrichtung: Istituto di Fisiologia Clinica (IFC), Consiglio Nazionale delle Ricerche (CNR), 53100 Siena, Italy. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nanomedicine has profoundly transformed the delivery of therapeutic agents by improving drug pharmacokinetics, protecting labile cargos, and expanding the therapeutic potential of a wide range of molecules [...]
Autor:innen und Institutionen
- Istituto di Fisiologia Clinica (IFC), Consiglio Nazionale delle Ricerche (CNR), 53100 Siena, Italy.
ORCID-Profile: Lisa Gherardini, Monia Taranta
Zitieren
APA
Gherardini, L., & Taranta, M. (2026). Cell-Mediated Drug Delivery: From Carriers to Therapeutics. Pharmaceutics, 18(7), 890. https://doi.org/10.3390/pharmaceutics18070890
Vancouver
Gherardini L, Taranta M. Cell-Mediated Drug Delivery: From Carriers to Therapeutics. Pharmaceutics. 2026;18(7):890. doi:10.3390/pharmaceutics18070890
BibTeX
@article{Gherardini2026,
author = {Gherardini, Lisa and Taranta, Monia},
title = {Cell-Mediated Drug Delivery: From Carriers to Therapeutics},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {7},
pages = {890},
doi = {10.3390/pharmaceutics18070890}
}
EUVIMED